The changing face of sympathetic overactivity in hypertension

References

• Facchini F S, Stoohs R A, Reaven G M. Enhanced sympathetic nervous system activity. The link between insulin resistance, hyperinsulinemia, and heart rate. Am J Hypertens 1996; 9: 1013–7
   PubMed Web of Science ®Google Scholar
• Julius S, Li Y, Brant D, Krause L, Buda A. Neurogenic pressor episodes fail to cause hypertension, but do induce cardiac hypertrophy. Hypertension 1989; 13: 422–9
   PubMed Web of Science ®Google Scholar
• Julius S, Jamerson K. Sympathetics, insulin resistance and coronary risk in hypertension: the ‘chicken-and-egg’ question. J Hypertens 1994; 12: 495–502
   PubMed Web of Science ®Google Scholar
• Julius S, Krause L, Schork N, Mejia A, Jones K, van de Ven C, et al. Hyperkinetic borderline hypertension in Tecumseh, Michigan. J Hypertens 1991; 9: 77–84
   PubMed Web of Science ®Google Scholar
• Esler M, Julius S, Zweifler A, Randall O, Harburg E, Gardiner H, et al. Mild high-renin essential hypertension: neurogenic human hypertension. N Engl J Med 1977; 296: 405–11
   PubMed Web of Science ®Google Scholar
• Young E A, Nesse R M, Weder A, Julius S. Anxiety and cardiovascular reactivity in the Tecumseh population. J Hypertens 1998; 16: 1727–33
   PubMed Web of Science ®Google Scholar
• Palatini P, Julius S. Heart rate and the cardiovascular risk. J Hypertens 1997; 15: 1–15
   PubMed Web of Science ®Google Scholar
• Devereux R B, Pickering T G, Harsfield G A, Kleinert H D, Denby L, Clark L, et al. Left ventricular hypertrophy in patients with hypertension: importance of blood pressure response to regularly recurring stress. Circulation 1983; 68: 470–6
   PubMed Web of Science ®Google Scholar
• Widimsky J, Fejfarova M H, Fejfar Z. Changes of cardiac output in hypertensive disease. Cardiologia 1957; 31: 381–9
   PubMedGoogle Scholar
• Lund-Johansen P. Hemodynamic alterations in early essential hypertension: recent advances. Mild hypertension: recent advances, F Gross, Strassen. Raven Press, New York, NY 1983; 237–49
   Google Scholar
• Eich R H, Peters R J, Cuddy R P, Smulyan H, Lyons R H. The hemodynamics in labile hypertension. Am Heart J 1962; 63: 188–95
   PubMed Web of Science ®Google Scholar
• Safar M E, Weiss Y A, Levenson J A, London G M, Milliez P L. Hemodynamic study of 85 patients with borderline hypertension. Am J Cardiol 1973; 31: 315–9
   PubMed Web of Science ®Google Scholar
• Messerli F H, Frochlich E D, Suarez D H, Reisin E, Dreslinski G R, Dunn F G, et al. Borderline hypertension: relationship between age, hemodynamics and circulating catecholamines. Circulation 1981; 64: 760–4
   PubMed Web of Science ®Google Scholar
• Eich R H, Cuddy R P, Smulyan H, Lyons R H. Hemodynamics in labile hypertension: a follow-up study. Circulation 1966; 34: 299–307
   PubMed Web of Science ®Google Scholar
• Julius R, Pascual A, London R. Role of sympathetic inhibition in the hyperkinetic type of borderline hypertension. Circulation 1971; 44: 413–8
   PubMed Web of Science ®Google Scholar
• Julius S, Conway J. Hemodynamic studies in patients with borderline blood pressure elevation. Circulation 1968; 38: 282–8
   PubMed Web of Science ®Google Scholar
• Anderson E A, Sinkey C A, Lawton W J, Mark A L. Elevated sympathetic nerve activity in borderline hypertensive humans: evidence from direct intraneural recordings. Hypertension 1989; 14: 177–83
   PubMed Web of Science ®Google Scholar
• Esler M, Jennings G, Lambert G. Noradrenaline release and the pathophysiology of primary human hypertension. Am J Hypertens 1989; 2((3 Pt 2))140s–46s
   Web of Science ®Google Scholar
• Guzzetti S, Piccaluga E, Casati R, Cerrutti S, Lombardi F, Pagani M, et al. Sympathetic predominance in essential hypertension. A study employing spectral analysis of heart rate variability. J Hypertens 1988; 6: 711–7
   PubMed Web of Science ®Google Scholar
• Bohm R, Van Baak M, Van Hooff M, Moy J, Rahn K H. Salivary flow in borderline hypertension. Klin Wochenschr 1985; 63(Suppl 3)154–6
   PubMedGoogle Scholar
• Kjeldsen S E, Gjesdal K, Eide I, Aakesson I, Amundsen R, Foss O P, et al. Increased beta-thromboglobulin in essential hypertension: interactions between arterial plasma adrenaline, platelet function and blood lipids. Acta Med Scand 1983; 213: 369–73
   PubMed Web of Science ®Google Scholar
• Tibblin G, Bergrentz S -E, Bjure J, Wilhelmsen L. Hematocrit, plasma protein, plasma volume, and viscosity in early hypertensive disease. Am Heart J 1966; 72: 165–76
   PubMed Web of Science ®Google Scholar
• Geisbock W. The meaning of blood pressure management for practice (in German). Dtsch Arch Klin Med 1905; 83: 363–74
   Google Scholar
• Julius R, Pascual A, Reilly K, London R. Abnormalities of plasma volume in borderline hypertension. Arch Int Med 1971; 127: 116–9
   PubMed Web of Science ®Google Scholar
• Letcher R L, Chien S, Pickering T G, Laragh J H. Elevated blood viscosity in patients with borderline essential hypertension. Hypertension 1983; 5: 757–62
   PubMed Web of Science ®Google Scholar
• Cohn J N. Relationship of plasma volume changes to resistance and capacitance vessel effects of sympathomimetic amines and angiotensin in man. Clin Sci 1966; 30: 267–78
   PubMed Web of Science ®Google Scholar
• Julius R, Pascual A, Abbrecht P, London R. Effect of beta-adrenergic blockade on plasma volume in human subjects. Proc Soc Exp Biol Med 1972; 140: 982–5
   PubMed Web of Science ®Google Scholar
• Smith S, Julius S, Jamerson K, Amerena J, Schork N. Hematocrit levels and physiologic factors in relationship to cardiovascular risk in Tecumseh, Michigan. Hypertension 1994; 12: 455–62
   Web of Science ®Google Scholar
• Guyton A C, Coleman T G. Quantitative analysis of the pathophysiology of hypertension. Circ Re5 1969; 24((5 SUPPI))1–19
   PubMedGoogle Scholar
• Pollare T, Lithell H, Morlin C, Prantare H, Hvarfner A, Ljunghall S. Metabolic effects of diltiazem and atenolol. Results from a randomized, double-blind study with parallel groups. J Hypertens 1989; 7: 551–9
   PubMed Web of Science ®Google Scholar
• Kjeldsen S E, Moan A, Petrin J, Weder A, Julius S. Effects of increased arterial epinephrine on insulin, glucose and phosphate. Blood Pressure 1996; 5: 25–31
   Google Scholar
• Folkow B. Physiological aspects of primary hypertension. Physiol Rev 1982; 62: 347–503
   PubMed Web of Science ®Google Scholar
• Egan B, Panis R, Hinderliter A, Schork N, Julius S. Mechanism of increased alpha-adrenergic vasoconstriction in human essential hypertension. J Clin Invest 1987; 80: 812–7
   PubMed Web of Science ®Google Scholar
• Hart M N, Heistad D D, Brody M J. Effect of chronic hypertension and sympathetic denervation on wall/lumen ratio of cerebral vessels. Hypertension 1980; 2: 419–28
   PubMed Web of Science ®Google Scholar
• Bevan R D, Tsuru H, Bevan J H. Cerebral artery mass in the rabbit is reduced by chronic sympathetic denervation. Stroke 1983; 14: 393–6
   PubMed Web of Science ®Google Scholar
• MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, et al. Blood pressure, stroke, and coronary heart disease. Part I, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335: 765–74
   PubMed Web of Science ®Google Scholar
• Collins R, Peto R, MacMahon S, Herbert P, Fiebach N H, Eberlein K A, et al. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reduction in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990; 335: 827–38
   PubMed Web of Science ®Google Scholar
• Julius S, Jamerson K, Mejia A, Krause L, Schork N, Jones K. The association of borderline hypertension with target organ changes and higher coronary risk. Tecumseh Blood Pressure Study. JAMA 1990; 264: 354–8
   PubMed Web of Science ®Google Scholar
• Keys A, Taylor H L, Blackburn H. Mortality and coronary heart disease among men- studies for 23 years. Arch Int Med 1971; 128: 201–14
   PubMed Web of Science ®Google Scholar
• Pyörälä K, Savolainen E, Kaukola S, Haapakoski J. Plasma insulin as a coronary heart disease risk factor: relationship to the other risk factors and predictive value during 9 1/2 year follow-up of the Helsinki Policemen Study. Acta Med Stand Suppl 1985; 701: 38–52
   PubMedGoogle Scholar
• Welborn T A, Wearne K. Coronary heart incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentration. Diabetes Care 1979; 2: 154–60
   PubMedGoogle Scholar
• Ducimetiere P, Eschwege E, Papoz L, Richard J L, Claude J R, Rosselin G. Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population. Diabetologia 1980; 19: 205–210
   PubMed Web of Science ®Google Scholar
• Julius S, Gudbrandsson T, Jamerson K, Shahab S T, Andersson O. Hypothesis. The hemodynamic link between insulin resistance and hypertension. J Hypertens 1991; 9: 983–6
   PubMed Web of Science ®Google Scholar
• Julius S, Gudbrandsson T, Jamerson K, Andersson O. The interconnection between sympathetics, microcirculation, and insulin resistance in hypertension. Blood Pressure 1992; 1: 9–19
   PubMedGoogle Scholar
• Johlin-Danfelt A, Frisk-Holmberg F, Karlsson J, Tesch P. Central and peripheral circulation in relation to muscle-fiber composition in normo- and hypertensive men. Clin Sci 1979; 56: 335–40
   Web of Science ®Google Scholar
• Jamerson K, Julius S, Gudbrandsson T, Andersson O, Brant D O. Reflex sympathetic activation induces acute insulin resistance in the human forearm. Hypertension 1993; 21: 618–23
   PubMed Web of Science ®Google Scholar
• Pollare T, Lithell H, Selinus L, Berne C. Application of prazosin is associated with an increase of insulin sensitivity in obese patients with hypertension. Diabetologia 1988; 31: 415–20
   PubMed Web of Science ®Google Scholar
• Krotkiewski M, Bylund-Fallenius A -C, Holm J, Bjorntorp P, Grimby G, Mandroukas K. Relationship between muscle morphology and metabolism in obese women: the effects of long-term physical training. Eur J Clin Invest 1983; 13: 5–12
   PubMed Web of Science ®Google Scholar
• Salonen J T, Lakka T A, Lakka H M, Valkonen V P, Everson S A, Kaplan G A. Hyperinsulinemia is associated with the incidence of hypertension and dyslipidemia in middle-aged men. Diabetes 1998; 47: 270–5
   PubMed Web of Science ®Google Scholar
• Donahue R P, Bean J A, DeCarlo R, Goldberg R B, Prineas R J. Does insulin resistance unite the separate components of the insulin resistance syndrome? Evidence from the Miami Community Health Study. Arterioscler Thromb Bid 1997; 17: 2413–7
   PubMed Web of Science ®Google Scholar
• Pyörälä M, Miettinen H, Laakso M, Pyörälä K. Hyperinsulinemia predicts coronary heart disease risk in healthy middle-aged men: the 22–year follow-up results of the Helsinki Policemen Study. Circulation 1998; 98: 398–404
   PubMed Web of Science ®Google Scholar
• Landsberg L. Diet, obesity and hypertension: a hypothesis involving insulin, the sympathetic nervous system and adaptive thermogenesis. Q J Med 1986; 61: 1081–90
   PubMedGoogle Scholar
• Grassi G, Seravalle G, Colombo M, Bolla G, Cattaneo B, Cavagnini F, et al. Body weight reduction, sympathetic nerve traffic, and arterial baroreflex in obese normotensive humans. Circulation 1998; 97: 2037–42
   PubMed Web of Science ®Google Scholar
• Ferrannini E, Buzzigoli G, Bonnadonna, Giorico M A, Oleggini M, Gradiadei L, et al. Insulin resistance in essential hypertension. N Engl J Med 1987; 317: 350–7
   PubMed Web of Science ®Google Scholar
• Julius S, Valentini M, Palatini P. Overweight and hypertension. A 2-way street. Hypertension 2000; 35: 807–13
   PubMed Web of Science ®Google Scholar